Lorimer is one of TalkMarkets' most prolific contributors with +2700 articles, +8000 followers and +22 million equity points to date. He focuses on the AI and semiconductor sectors and cannabis and psychedelic compound-based clinical stage stocks. Sign up to follow his latest articles and have your ...
moreLorimer is one of TalkMarkets' most prolific contributors with +2700 articles, +8000 followers and +22 million equity points to date. He focuses on the AI and semiconductor sectors and cannabis and psychedelic compound-based clinical stage stocks. Sign up to follow his latest articles and have your say in the Comment section.
less
